Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO–(BUSINESS WIRE)–Janux Therapeutics today announced the appointment of Vickie Capps and Sheila Gujrathi, M.D., as independent members of the Company’s Board of Directors. Ms. Capps is an experienced senior finance and audit professional with…
Service helps oncology pharmacies streamline benefits investigation, prior authorization and financial assistance support for practices with Medically Integrated Dispensing
IRVING, Texas–(BUSINESS WIRE)–McKesson, a global leader in healthcare dedica…
CAMBRIDGE, England, & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced t…
GENEVA–(BUSINESS WIRE)–Selexis SA, a JSR Life Sciences company, and SpyBiotech, a biotechnology company with a novel vaccine platform, have signed a commercial license agreement (CLA) to advance SPYVLP102, SpyBiotech’s lead vaccine program for human …
GENEVA–(BUSINESS WIRE)–Selexis SA, a JSR Life Sciences company, and SpyBiotech, a biotechnology company with a novel vaccine platform, have signed a commercial license agreement (CLA) to advance SPYVLP102, SpyBiotech’s lead vaccine program for human …
GENEVA–(BUSINESS WIRE)–Selexis SA, a JSR Life Sciences company, and SpyBiotech, a biotechnology company with a novel vaccine platform, have signed a commercial license agreement (CLA) to advance SPYVLP102, SpyBiotech’s lead vaccine program for human …
GENEVA–(BUSINESS WIRE)–Selexis SA, a JSR Life Sciences company, and SpyBiotech, a biotechnology company with a novel vaccine platform, have signed a commercial license agreement (CLA) to advance SPYVLP102, SpyBiotech’s lead vaccine program for human …
New End-to-End Compliant-Ready Workflow Helps Biotherapeutic Protein Manufacturers Meet Regulatory and Attribute-Based Product Analysis Requirements for Drug Identity, Purity, and Quality
NEWS SUMMARY:
New Peptide MAM (multi-attribute method) workf…
New End-to-End Compliant-Ready Workflow Helps Biotherapeutic Protein Manufacturers Meet Regulatory and Attribute-Based Product Analysis Requirements for Drug Identity, Purity, and Quality
NEWS SUMMARY:
New Peptide MAM (multi-attribute method) workf…
New End-to-End Compliant-Ready Workflow Helps Biotherapeutic Protein Manufacturers Meet Regulatory and Attribute-Based Product Analysis Requirements for Drug Identity, Purity, and Quality
NEWS SUMMARY:
New Peptide MAM (multi-attribute method) workf…